5 tulemused
Background:
Moderate acute malnutrition (MAM), a major global health problem, is defined as wasting (i.e. weight-for-height between <-2 and -3 Z-scores of the WHO Child Growth Standards) and/or mid-upper-arm circumference (MUAC) greater or equal to 115 mm and less than 125 mm. According to the
Background:
Moderate acute malnutrition (MAM), a major global health problem, is defined as wasting (i.e. weight-for-height between < -2 and -3 Z-scores of the WHO Child Growth Standards) and/or mid-upper-arm circumference (MUAC) greater or equal to 115 mm and less than 125 mm. According to the
Investigators will conduct 3 Pre-POC studies among 12-18 month old children with MAM (WLZ <-2 to -3) and stunting (LAZ <-2 to -3) over the course of approximately two years.
Study design: Randomized controlled intervention trial.
Study site: This study will be conducted at Bauniabadh, Mirpur in
TITLE: Clinical tolerance of a live, attenuated influenza vaccine (FluMist®) in the context of influenza immunization in a population of egg-allergic children: A pilot project. Protocol #: FluMist240713.
1. INTRODUCTION
In Canada, the flu vaccine is indicated for all children between 6 and 23 months
Specific Aim 1: Implement an integrated protocol in Sierra Leone for the management of MAM and non-complicated SAM that uses a single anthropometric indicator as well as the same food. Standard care refers to traditional, segregated treatment of MAM and SAM.
Hypothesis: An integrated management